Reaction Details |
| Report a problem with these data |
Target | C-C chemokine receptor type 5 |
---|
Ligand | BDBM50339959 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_739992 (CHEMBL1763052) |
---|
IC50 | 290±n/a nM |
---|
Citation | Skerlj, R; Bridger, G; Zhou, Y; Bourque, E; Langille, J; Di Fluri, M; Bogucki, D; Yang, W; Li, T; Wang, L; Nan, S; Baird, I; Metz, M; Darkes, M; Labrecque, J; Lau, G; Fricker, S; Huskens, D; Schols, D Design and synthesis of pyridin-2-yloxymethylpiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication. Bioorg Med Chem Lett21:2450-5 (2011) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
C-C chemokine receptor type 5 |
---|
Name: | C-C chemokine receptor type 5 |
Synonyms: | C-C CKR-5 | C-C chemokine receptor type 5 | CC-CKR-5 | CCR-5 | CCR5 | CCR5/mu opioid receptor complex | CCR5_HUMAN | CD_antigen=CD195 | CHEMR13 | CMKBR5 | HIV-1 fusion coreceptor |
Type: | Enzyme |
Mol. Mass.: | 40540.21 |
Organism: | Homo sapiens (Human) |
Description: | P51681 |
Residue: | 352 |
Sequence: | MDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKR
LKSMTDIYLLNLAISDLFFLLTVPFWAHYAAAQWDFGNTMCQLLTGLYFIGFFSGIFFII
LLTIDRYLAVVHAVFALKARTVTFGVVTSVITWVVAVFASLPGIIFTRSQKEGLHYTCSS
HFPYSQYQFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRCRNEKKRHRAVRLIFTI
MIVYFLFWAPYNIVLLLNTFQEFFGLNNCSSSNRLDQAMQVTETLGMTHCCINPIIYAFV
GEKFRNYLLVFFQKHIAKRFCKCCSIFQQEAPERASSVYTRSTGEQEISVGL
|
|
|
BDBM50339959 |
---|
n/a |
---|
Name | BDBM50339959 |
Synonyms: | (E)-3-(3-(4-((4-bromophenyl)(ethoxyimino)methyl)piperidin-1-yl)butylcarbamoyl)-2,4-dimethylpyridine 1-oxide | CHEMBL1762304 |
Type | Small organic molecule |
Emp. Form. | C26H35BrN4O3 |
Mol. Mass. | 531.485 |
SMILES | CCO[N-][C+](C1CCN(CC1)C(C)CCNC(=O)c1c(C)cc[n+]([O-])c1C)c1ccc(Br)cc1 |
Structure |
|